Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Familial sarcoma: challenging pedigrees.

Henry T Lynch1, Carolyn A Deters, David Hogg

  • 1Department of Preventive Medicine, Creighton University School of Medicine, Omaha, Nebraska 68178, USA. htlynch@creighton.edu

Cancer
|October 30, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-simulated clinical consultations: Assessing the potential of ChatGPT to support medical training.

Archives of disease in childhood·2026
Same author

Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors.

JTO clinical and research reports·2025
Same author

Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): pilot study of an electronic health record machine learning algorithm-guided intervention to identify undiagnosed atrial fibrillation.

Open heart·2023
Same author

Incident cardiovascular, renal, metabolic diseases and death in individuals identified for risk-guided atrial fibrillation screening: a nationwide cohort study.

Open heart·2023
Same author

Gene and pathway based burden analyses in familial lymphoid cancer cases: Rare variants in immune pathway genes.

PloS one·2023
Same author

Prediction of short-term atrial fibrillation risk using primary care electronic health records.

Heart (British Cardiac Society)·2023

Understanding hereditary sarcoma is crucial for earlier diagnosis and targeted therapies. This study highlights genetic heterogeneity in sarcoma-prone families, revealing diverse cancer syndromes linked to specific gene mutations.

Area of Science:

  • Oncology
  • Genetics
  • Cancer Epidemiology

Background:

  • Soft tissue and osteogenic sarcomas are rare, with limited understanding of their hereditary causes.
  • Improved knowledge of genetic and environmental factors could enhance diagnosis and therapy for sarcomas.

Purpose of the Study:

  • To investigate the hereditary etiology of sarcomas by examining sarcoma-prone families.
  • To characterize the diagnostic, surveillance, and management challenges in these families.

Main Methods:

  • Selected 10 sarcoma-prone families from a hereditary cancer resource.
  • Compiled detailed family cancer histories and verified medical/pathology records.
  • Provided genetic counseling before DNA collection and result disclosure.

Related Experiment Videos

Main Results:

  • Observed significant phenotypic and genotypic heterogeneity among families.
  • Identified one family with 16 sarcoma cases, including individuals with multiple metachronous sarcomas.
  • Found associations between sarcoma and malignant melanoma (CDKN2A mutation), pancreatic cancer, hereditary nonpolyposis colorectal carcinoma (MSH2 mutation), breast cancer (BRCA1 mutation), and Li-Fraumeni syndrome (p53 mutation).

Conclusions:

  • Sarcoma-prone families exhibit diverse clinicopathology and compliance, underscoring the role of genetic factors.
  • Understanding this heterogeneity is key to elucidating the etiologic role of genetics in sarcoma development.
  • A lack of population-based data was a limitation in this study.